In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium
暂无分享,去创建一个
C. Wemmert | G. Forestier | F. Feuerhake | J. Alfonso | H. Hatzikirou | Cédric Wemmert | R. Schönmeyer | N. S. Schaadt | J. C. L. Alfonso | N. Brieu | R. Schönmeyer | N. Brieu | G. Forestier | F. Feuerhake | H. Hatzikirou | N. Schaadt
[1] T. Anderson,et al. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. , 1988, The American journal of pathology.
[2] Alan Mackay,et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. , 2004, Cancer research.
[3] Mina J. Bissell,et al. Myoepithelial Cells: Their Origin and Function in Breast Morphogenesis and Neoplasia , 2005, Journal of Mammary Gland Biology and Neoplasia.
[4] R. Guzman,et al. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] C. Maier,et al. Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle , 2005, Breast Cancer Research.
[6] T. Anderson,et al. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. , 1981, British Journal of Cancer.
[7] K. Lohman,et al. DNA damage and breast cancer risk. , 2003, Carcinogenesis.
[8] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[9] J. Russo,et al. Histological Evaluation of the Normal Breast , 2014 .
[10] F. Rodier,et al. DDR-mediated crosstalk between DNA-damaged cells and their microenvironment , 2015, Front. Genet..
[11] Michael R. Elliott,et al. Clearance of apoptotic cells: implications in health and disease , 2010, The Journal of cell biology.
[12] S. Cullen,et al. Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells. , 2013, Molecular cell.
[13] D. Dudley,et al. The immune system in health and disease. , 1992, Bailliere's clinical obstetrics and gynaecology.
[14] W. Zou. Regulatory T cells, tumour immunity and immunotherapy , 2006, Nature Reviews Immunology.
[15] T. Nielsen,et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] P. Norman,et al. Immunobiology: The immune system in health and disease , 1995 .
[17] E. Sandgren,et al. Mammary carcinogenesis is preceded by altered epithelial cell turnover in transforming growth factor-alpha and c-myc transgenic mice. , 2006, The American journal of pathology.
[18] P. Unterberger,et al. Cell Proliferation, Apoptosis, and Expression of Bcl-2 and Bax in Non-Lactating Human Breast Epithelium in Relation to the Menstrual Cycle and Reproductive History , 2004, Breast Cancer Research and Treatment.
[19] Jens V Stein,et al. How chemokines invite leukocytes to dance , 2008, Nature Immunology.
[20] Karin Jirström,et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. , 2011, Cancer discovery.
[21] L. Beck,et al. Chemokines: key players in innate and adaptive immunity. , 2005, The Journal of investigative dermatology.
[22] Kornelia Polyak,et al. Breast cancer: origins and evolution. , 2007, The Journal of clinical investigation.
[23] E. Ranieri. Cytotoxic T-Cells , 2014, Methods in Molecular Biology.
[24] R. Vierkant,et al. Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues , 2012, Breast Cancer Research and Treatment.
[25] J. Bartek,et al. The DNA-damage response in human biology and disease , 2009, Nature.
[26] L. Coussens,et al. Leukocytes in mammary development and cancer. , 2011, Cold Spring Harbor perspectives in biology.
[27] Karin Jirström,et al. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients , 2012, BMC Cancer.
[28] G. Garinis,et al. DNA damage and innate immunity: links and trade-offs. , 2014, Trends in immunology.
[29] A. Douglas-Jones,et al. Lymphocytic lobulitis in breast core biopsy: a peritumoral phenomenon , 2006, Histopathology.
[30] Carsten Denkert,et al. Clinical relevance of host immunity in breast cancer: from TILs to the clinic , 2016, Nature Reviews Clinical Oncology.
[31] M. Erlacher,et al. How cell death shapes cancer , 2015, Cell Death and Disease.
[32] G. Feldman,et al. Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2 , 2010, Genetics in Medicine.
[33] A. Mantovani,et al. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.
[34] S. Narod. Modifiers of risk of hereditary breast cancer , 2006, Oncogene.
[35] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[36] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[37] David Depoil,et al. Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[38] Derek C. Radisky,et al. Immune cell quantitation in normal breast tissue lobules with and without lobulitis , 2014, Breast Cancer Research and Treatment.
[39] Nicolas Brieu,et al. Slide-specific models for segmentation of differently stained digital histopathology whole slide images , 2016, SPIE Medical Imaging.
[40] L. Happerfield,et al. Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast. , 1996, British Journal of Cancer.
[41] A. Thor,et al. Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[42] Craig Murdoch,et al. The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.
[43] A. Ribas,et al. The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? , 2015, Current opinion in immunology.
[44] G. Collins. The next generation. , 2006, Scientific American.
[45] D. Green,et al. To Be or Not to Be? How Selective Autophagy and Cell Death Govern Cell Fate , 2014, Cell.
[46] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[47] Sylvain V Costes,et al. Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies , 2010, Breast Cancer Research.
[48] J. Campisi,et al. Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.
[49] P. Glazer,et al. Interplay between DNA repair and inflammation, and the link to cancer , 2014, Critical reviews in biochemistry and molecular biology.
[50] A. Andres,et al. Apoptosis in the Estrous and Menstrual Cycles , 1999, Journal of Mammary Gland Biology and Neoplasia.
[51] Cathrin Brisken,et al. Progesterone signalling in breast cancer: a neglected hormone coming into the limelight , 2013, Nature Reviews Cancer.
[52] Celeste M. Nelson,et al. Integrated morphodynamic signalling of the mammary gland , 2011, Nature Reviews Molecular Cell Biology.
[53] R. Chetty,et al. Lymphocytic mastopathy associated with infiltrating lobular breast carcinoma. , 1993, Journal of clinical pathology.
[54] M. Stampfer,et al. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[56] E. Tartour,et al. Immune infiltration in human tumors: a prognostic factor that should not be ignored , 2010, Oncogene.
[57] Lisa M. Coussens,et al. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression , 2007 .
[58] S. Powell,et al. BRCA1 and BRCA2: different roles in a common pathway of genome protection , 2011, Nature Reviews Cancer.
[59] Paul J van Diest,et al. Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer , 2005, The Journal of pathology.
[60] Seema A. Khan,et al. Morphological Changes in Breast Tissue with Menstrual Cycle , 2002, Modern Pathology.
[61] C. Caldon,et al. Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers , 2014, Front. Oncol..
[62] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[63] E. Thompson,et al. Hormonal regulation of physiological cell turnover and apoptosis , 2000, Cell and Tissue Research.
[64] A. Howell,et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. , 1988, British Journal of Cancer.
[65] M. Coffey,et al. DNA mismatch repair and the transition to hormone independence in breast and prostate cancer. , 2010, Cancer letters.
[66] Dimitris Kletsas,et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.
[67] L. Coussens,et al. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression , 2007, Breast Cancer Research.
[68] Ian O Ellis,et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] I. Weissman,et al. Programmed cell removal: a new obstacle in the road to developing cancer , 2011, Nature Reviews Cancer.
[70] V. Band,et al. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[71] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[72] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[73] Z. Werb,et al. Roles of the Innate Immune System in Mammary Gland Remodeling During Involution , 2007, Journal of Mammary Gland Biology and Neoplasia.
[74] S. Ostrand-Rosenberg,et al. Immune surveillance: a balance between protumor and antitumor immunity. , 2008, Current opinion in genetics & development.
[75] J. Russo,et al. Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland , 1999, Breast Cancer Research and Treatment.
[76] G. Merlino. Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice. , 1994, Seminars in cancer biology.
[77] G. Raab,et al. Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality. , 1982, British Journal of Cancer.
[78] Mark J. Smyth,et al. Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.
[79] Antje Sommer,et al. Theory Of Simple Liquids , 2016 .
[80] R. Dymock. Origins and Evolution , 2010 .
[81] Gavin P Dunn,et al. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. , 2006, Advances in immunology.
[82] R. Schreiber,et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.
[83] Katherine M White,et al. A randomised controlled trial of a theory-based intervention to improve sun protective behaviour in adolescents ('you can still be HOT in the shade'): study protocol , 2012, BMC Cancer.
[84] Bernhard Moser,et al. Lymphocyte traffic control by chemokines , 2001, Nature Immunology.
[85] C. Sweeney,et al. Lobulitis in nonneoplastic breast tissue from breast cancer patients: association with phenotypes that are common in hereditary breast cancer. , 2014, Human Pathology.
[86] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[87] C. Janeway. Immunobiology: The Immune System in Health and Disease , 1996 .